These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 14962098)

  • 1. Sezary syndrome cells unlike normal circulating T lymphocytes fail to migrate following engagement of NT1 receptor.
    Magazin M; Poszepczynska-Guigné E; Bagot M; Boumsell L; Pruvost C; Chalon P; Culouscou JM; Ferrara P; Bensussan A
    J Invest Dermatol; 2004 Jan; 122(1):111-8. PubMed ID: 14962098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysregulation of lymphocyte interleukin-12 receptor expression in Sézary syndrome.
    Zaki MH; Shane RB; Geng Y; Showe LC; Everetts SE; Presky DH; Wysocka M; Moore JS; Rook AH
    J Invest Dermatol; 2001 Jul; 117(1):119-27. PubMed ID: 11442758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional characterization of neurotensin receptors in human cutaneous T cell lymphoma malignant lymphocytes.
    Ramez M; Bagot M; Nikolova M; Boumsell L; Vita N; Chalon P; Caput D; Ferrara P; Bensussan A
    J Invest Dermatol; 2001 Sep; 117(3):687-93. PubMed ID: 11564178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engagement of ILT2/CD85j in Sézary syndrome cells inhibits their CD3/TCR signaling.
    Nikolova M; Musette P; Bagot M; Boumsell L; Bensussan A
    Blood; 2002 Aug; 100(3):1019-25. PubMed ID: 12130517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and function of the natural cytotoxicity receptor NKp46 on circulating malignant CD4+ T lymphocytes of Sézary syndrome patients.
    Bensussan A; Remtoula N; Sivori S; Bagot M; Moretta A; Marie-Cardine A
    J Invest Dermatol; 2011 Apr; 131(4):969-76. PubMed ID: 21191411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating clonal CLA(+) and CD4(+) T cells in Sezary syndrome express the skin-homing chemokine receptors CCR4 and CCR10 as well as the lymph node-homing chemokine receptor CCR7.
    Sokolowska-Wojdylo M; Wenzel J; Gaffal E; Lenz J; Speuser P; Erdmann S; Abuzahra F; Bowman E; Roszkiewicz J; Bieber T; Tüting T
    Br J Dermatol; 2005 Feb; 152(2):258-64. PubMed ID: 15727636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bexarotene blunts malignant T-cell chemotaxis in Sezary syndrome: reduction of chemokine receptor 4-positive lymphocytes and decreased chemotaxis to thymus and activation-regulated chemokine.
    Richardson SK; Newton SB; Bach TL; Budgin JB; Benoit BM; Lin JH; Yoon JS; Wysocka M; Abrams CS; Rook AH
    Am J Hematol; 2007 Sep; 82(9):792-7. PubMed ID: 17546636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurotensin causes tyrosine phosphorylation of focal adhesion kinase in lung cancer cells.
    Leyton J; Garcia-Marin L; Jensen RT; Moody TW
    Eur J Pharmacol; 2002 May; 442(3):179-86. PubMed ID: 12065070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-21 enhances antitumor responses without stimulating proliferation of malignant T cells of patients with Sézary syndrome.
    Yoon JS; Newton SM; Wysocka M; Troxel AB; Hess SD; Richardson SK; Lin JH; Benoit BM; Kasprzycka M; Wasik MA; Rook AH
    J Invest Dermatol; 2008 Feb; 128(2):473-80. PubMed ID: 17713571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression of a novel early activation surface membrane receptor in cutaneous T cell lymphoma cells.
    Nikolova M; Tawab A; Marie-Cardine A; Bagot M; Boumsell L; Bensussan A
    J Invest Dermatol; 2001 May; 116(5):731-8. PubMed ID: 11348462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell surface differentiation antigens of the malignant T cell in Sezary syndrome and mycosis fungoides.
    Haynes BF; Bunn P; Mann D; Thomas C; Eisenbarth GS; Minna J; Fauci AS
    J Clin Invest; 1981 Feb; 67(2):523-30. PubMed ID: 6970206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sezary syndrome. I. Specific skin-directed migration of peripheral blood lymphocytes.
    Laroche L; Papiernik M; Bach JF
    J Immunol; 1983 May; 130(5):2467-70. PubMed ID: 6601151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-7 is a growth factor for Sézary lymphoma cells.
    Dalloul A; Laroche L; Bagot M; Mossalayi MD; Fourcade C; Thacker DJ; Hogge DE; Merle-Béral H; Debré P; Schmitt C
    J Clin Invest; 1992 Sep; 90(3):1054-60. PubMed ID: 1381718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ephrin-A1 binding to CD4+ T lymphocytes stimulates migration and induces tyrosine phosphorylation of PYK2.
    Aasheim HC; Delabie J; Finne EF
    Blood; 2005 Apr; 105(7):2869-76. PubMed ID: 15585656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression pattern of chemokine receptors and chemokine release in inflammatory erythroderma and Sézary syndrome.
    Fierro MT; Comessatti A; Quaglino P; Ortoncelli M; Osella Abate S; Ponti R; Novelli M; Bernengo MG
    Dermatology; 2006; 213(4):284-92. PubMed ID: 17135733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Killer cell immunoglobulin-like receptor expression delineates in situ Sézary syndrome lymphocytes.
    Wechsler J; Bagot M; Nikolova M; Parolini S; Martin-Garcia N; Boumsell L; Moretta A; Bensussan A
    J Pathol; 2003 Jan; 199(1):77-83. PubMed ID: 12474229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating natural killer lymphocytes are potential cytotoxic effectors against autologous malignant cells in sezary syndrome patients.
    Bouaziz JD; Ortonne N; Giustiniani J; Schiavon V; Huet D; Bagot M; Bensussan A
    J Invest Dermatol; 2005 Dec; 125(6):1273-8. PubMed ID: 16354199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo imaging of cutaneous T-cell lymphoma migration to the skin.
    Hoeller C; Richardson SK; Ng LG; Valero T; Wysocka M; Rook AH; Weninger W
    Cancer Res; 2009 Apr; 69(7):2704-8. PubMed ID: 19318575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new monoclonal antibody (CH-F42) recognizes a CD7- subset of normal T lymphocytes and circulating malignant cells in adult T-cell lymphoma-leukemia and Sézary syndrome.
    Labastide WB; Rana MT; Barker CR
    Blood; 1990 Oct; 76(7):1361-8. PubMed ID: 1698478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. mu-Opioid receptor is induced by IL-13 within lymph nodes from patients with Sézary syndrome.
    Bénard A; Cavaillès P; Boué J; Chapey E; Bayry J; Blanpied C; Meyer N; Lamant L; Kaveri SV; Brousset P; Dietrich G
    J Invest Dermatol; 2010 May; 130(5):1337-44. PubMed ID: 20107485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.